Nodal contributes to cisplatin resistance in ovarian cancer cells.

被引：0
|
作者：
Bilyk, Olena [1 ]
Postovit, Lvnne-Marie [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.OVCA15-A65
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A65
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
    Bao, Lingjie
    Jaramillo, Melba C.
    Zhang, Zhenbo
    Zheng, Yunxi
    Yao, Ming
    Zhang, Donna D.
    Yi, Xiaofang
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 91 - 98
  • [2] SREBP2 contributes to cisplatin resistance in ovarian cancer cells
    Zheng, Lei
    Li, Li
    Lu, Yun
    Jiang, Fangfang
    Yang, Xiu-An
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (07) : 655 - 662
  • [3] Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells
    Yu, Pei-Ning
    Yan, Ming-De
    Lai, Hung-Cheng
    Huang, Rui-Lan
    Chou, Yu-Ching
    Lin, Wen-Chi
    Yeh, Li-Tzu
    Lin, Ya-Wen
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (03) : 542 - 551
  • [4] HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells
    Long, Fangyi
    Liu, Weixin
    Jia, Ping
    Wang, Huafei
    Jiang, Gang
    Wang, Ting
    PHARMAZIE, 2018, 73 (09): : 533 - 536
  • [5] Mifepristone enhances cisplatin toxicity in ovarian cancer cells.
    Freeburg, Elizabeth M.
    Goyeneche, Alicia A.
    Telleria, Carlos M.
    BIOLOGY OF REPRODUCTION, 2006, : 120 - 121
  • [6] Integrin-linked kinase and proximal signaling contributes to the cisplatin resistance of ovarian cancer cells
    Soto, Daniel
    Valiyeva, Fatima
    Echevarria, Ileabett
    Reyes, Jeyshka
    Vivas-Mejia, Pablo E.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells
    Im-aram, Akechai
    Farrand, Lee
    Bae, Seung-Min
    Song, Gwonhwa
    Song, Yong Sang
    Han, Jae Yong
    Tsang, Benjamin K.
    PLOS ONE, 2013, 8 (09):
  • [8] Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells
    Srivastava, Amit Kumar
    Han, Chunhua
    Zhao, Ran
    Cui, Tiantian
    Dai, Yuntao
    Mao, Charlene
    Zhao, Weiqiang
    Zhang, Xiaoli
    Yu, Jianhua
    Wang, Qi-En
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (14) : 4411 - 4416
  • [9] UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
    Jin, Chengmeng
    Yu, Wei
    Lou, Xiaoyan
    Zhou, Fan
    Han, Xu
    Zhao, Na
    Lin, Biaoyang
    JOURNAL OF CANCER, 2013, 4 (08): : 662 - 670
  • [10] Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
    Hu, Sha
    Yu, Lili
    Li, Zhimin
    Shen, Yi
    Wang, Jing
    Cai, Jing
    Xiao, Lan
    Wang, Zehua
    CANCER BIOLOGY & THERAPY, 2010, 10 (08) : 788 - 795
12345